Filtration Designs Remove Processing Bottlenecks for High-Yield Biotech Drugs - Deep pleats and asymmetric pores increase the capacity and lifetime of a cartridge - BioPharm International

ADVERTISEMENT

Filtration Designs Remove Processing Bottlenecks for High-Yield Biotech Drugs
Deep pleats and asymmetric pores increase the capacity and lifetime of a cartridge


BioPharm International




Biotech companies are running into production bottlenecks because standard purification and separation technologies lack the capability to remove the elevated levels of biomass from high titer solutions. Recent developments in filter technology offer the biotech industry a cost-effective solution to processing challenges by reducing bottlenecks, thereby accelerating the time-to-market of new drugs.

This article focuses on new designs of sterilizing-grade filters that remove bacteria, toxins, and other contaminants from initial purification steps to final formulation and filling. We discuss these important parameters in filter selection: materials, compatibility, wettability, sterilization, adsorption, and membrane and filter construction.


Materials and Compatibility


Table 1. General compatibility of polymers for filtration
Three hydrophilic sterilizing-grade membrane materials are readily available: Nylon 6,6, polyvinylidene fluoride (PVDF), and polyether sulfone (PES). Table 1 summarizes the general compatibilities for each membrane type. PES and PVDF are low binding, water wettable and can be gamma irradiated. The membrane with the broadest pH compatibility is PES.

Wettability

The ability to wet a filter completely is important, because the objective is to use the full filtration area. If a significant portion of the membrane is not wetted properly, then the filtration flow can be impaired. In addition, it is necessary to have a fully wetted membrane during the performance of an integrity test. If the filter membrane is not completely wetted, then even a very small non-wetted area of the filter could cause a failure of the integrity test, causing process delays and re-testing.

In terms of wettability of membrane material, Nylon 6,6 is the most easily wetted because it is naturally hydrophilic. PVDF is naturally hydrophobic, and for liquid applications will under go some sort of modification to make the membrane hydrophilic. This version is close to Nylon 6,6 in terms of wettability. Most common PES filters do not wet easily and usually require backpressure to wet completely, making integrity testing more difficult and time consuming. However, recent improvements in PES wetting chemistry have rendered its wettability comparable to PVDF membrane filters.

Sterilization


Figure 1. This diagram depicts an asymmetric membrane with a 3:1 gradient in average pore size
Integrated single-use bioprocess systems incorporating filters, tubing, and bags can play a key role in helping companies to increase manufacturing capacity. A single-use capsule does not require cleaning or cleaning validation because it can be pre-sterilized via gamma irradiation by the manufacturer. This simplifies process operations because pre-sterilized filters do not require assembly or steam sterilization. The housing material used in capsule filters is also often polypropylene. For capsules that will be sterilized by gamma irradiation, the polypropylene must be gamma stable to ensure structural strength, compatibility, and low extractables.

Adsorption

The purpose of filtration is to remove a particular contaminant or groups of contaminants from the process feed. The filter system should not be adding anything significant (extractables) to the process fluid, nor should it remove a desired product component from the fluid that is being filtered.


blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Contract Research and Manufacturing Organization Paragon Bioservices Raises $13 Million
October 28, 2014
Yale and Gilead Extend Sequencing Initiative
October 28, 2014
Author Guidelines
Source: BioPharm International,
Click here